Effects of platelet-derived growth factor and interleukin-10 on Fas/Fas-ligand and Bcl-2/Bax mRNA expression in rat hepatic stellate cells in vitro

Figure 5 Relative Bcl-2/Bax mRNA expression levels in HSCs of different groups assessed by RT-PCR. A: Relative Bcl-2 mRNA expression levels (^bP < 0.01 vs group P, group I and group C, respectively; ^aP > 0.05 vs group I, ^cP > 0.05 vs group C, ^dP < 0.01 vs group P.). B: Relative Bax mRNA expression levels (^bP < 0.01 vs group P, group I and group C, respectively; ^aP > 0.05 vs group I, ^cP = 0.045 < 0.05 vs group C, ^dP < 0.01 vs group P.). Group N: Normal group as control; group P: PDGF treated group; group I: IL-10 treated group; group C: Combined PDGF and IL-10 treatment group.